Stoke Therapeutics: Impressive Pipeline And Big Backers
Source: SeekingAlpha
2025-06-15 23:27:38 ET
Headquartered in Bedford, MA, Stoke Therapeutics ( STOK ) was founded in 2014 with a focus on developing RNA-based medicines to treat severe diseases by increasing protein expression....
Read the full article on Seeking Alpha
For further details see:
Stoke Therapeutics: Impressive Pipeline And Big Backers
UCB SA
NASDAQ: UCBJF
UCBJF Trading
0.0% G/L:
$299.45 Last:
1 Volume:
$299.45 Open:
